Annual Current Assets
$299.85 M
-$122.94 M-29.08%
September 30, 2024
Summary
- As of February 8, 2025, ENTA annual total current assets is $299.85 million, with the most recent change of -$122.94 million (-29.08%) on September 30, 2024.
- During the last 3 years, ENTA annual current assets has fallen by -$19.17 million (-6.01%).
- ENTA annual current assets is now -31.36% below its all-time high of $436.84 million, reached on September 30, 2020.
Performance
ENTA Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$299.85 M
+$13.27 M+4.63%
September 30, 2024
Summary
- As of February 8, 2025, ENTA quarterly total current assets is $299.85 million, with the most recent change of +$13.27 million (+4.63%) on September 30, 2024.
- Over the past year, ENTA quarterly current assets has dropped by -$122.94 million (-29.08%).
- ENTA quarterly current assets is now -33.55% below its all-time high of $451.26 million, reached on June 30, 2019.
Performance
ENTA Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
ENTA Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.1% | -29.1% |
| 3 y3 years | -6.0% | -6.0% |
| 5 y5 years | -25.4% | -6.0% |
ENTA Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.1% | at low | -33.1% | +10.6% |
| 5 y | 5-year | -31.4% | at low | -33.1% | +10.6% |
| alltime | all time | -31.4% | +1094.7% | -33.5% | +1094.7% |
Enanta Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $76.80 M(+94.5%) | $299.85 M(+4.6%) |
| Jun 2024 | - | $286.58 M(-18.4%) |
| Mar 2024 | - | $351.03 M(-10.1%) |
| Dec 2023 | - | $390.30 M(-7.7%) |
| Sep 2023 | $39.48 M(-38.0%) | $422.79 M(-5.7%) |
| Jun 2023 | - | $448.46 M(+65.4%) |
| Mar 2023 | - | $271.14 M(-4.4%) |
| Dec 2022 | - | $283.70 M(-9.0%) |
| Sep 2022 | $63.70 M(-46.8%) | $311.71 M(-0.4%) |
| Jun 2022 | - | $313.04 M(-8.4%) |
| Mar 2022 | - | $341.87 M(+4.6%) |
| Dec 2021 | - | $326.96 M(+2.5%) |
| Sep 2021 | $119.77 M(+143.0%) | $319.02 M(-0.7%) |
| Jun 2021 | - | $321.15 M(-25.0%) |
| Mar 2021 | - | $428.22 M(-4.0%) |
| Dec 2020 | - | $445.94 M(+2.1%) |
| Sep 2020 | $49.30 M(-44.0%) | $436.84 M(+5.7%) |
| Jun 2020 | - | $413.38 M(+2.7%) |
| Mar 2020 | - | $402.71 M(-8.6%) |
| Dec 2019 | - | $440.51 M(+9.6%) |
| Sep 2019 | $87.98 M(+160.0%) | $401.85 M(-11.0%) |
| Jun 2019 | - | $451.26 M(+6.5%) |
| Mar 2019 | - | $423.84 M(+0.1%) |
| Dec 2018 | - | $423.31 M(+11.3%) |
| Sep 2018 | $33.84 M | $380.39 M(+11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $339.89 M(+11.2%) |
| Mar 2018 | - | $305.68 M(+23.4%) |
| Dec 2017 | - | $247.63 M(+4.1%) |
| Sep 2017 | $88.82 M(+80.8%) | $237.82 M(+15.4%) |
| Jun 2017 | - | $206.12 M(+8.1%) |
| Mar 2017 | - | $190.59 M(-14.9%) |
| Dec 2016 | - | $224.06 M(-3.5%) |
| Sep 2016 | $49.12 M(-34.8%) | $232.16 M(-4.0%) |
| Jun 2016 | - | $241.79 M(-0.4%) |
| Mar 2016 | - | $242.66 M(+16.1%) |
| Dec 2015 | - | $209.02 M(+22.5%) |
| Sep 2015 | $75.37 M(+58.9%) | $170.64 M(-1.2%) |
| Jun 2015 | - | $172.64 M(-2.9%) |
| Mar 2015 | - | $177.78 M(-4.0%) |
| Dec 2014 | - | $185.10 M(+71.4%) |
| Sep 2014 | $47.44 M(+286.9%) | $107.97 M(-3.3%) |
| Jun 2014 | - | $111.68 M(+12.4%) |
| Mar 2014 | - | $99.35 M(+5.3%) |
| Dec 2013 | - | $94.38 M(-9.9%) |
| Sep 2013 | $12.26 M(+152.6%) | $104.71 M(+7.0%) |
| Jun 2013 | - | $97.87 M(-12.4%) |
| Mar 2013 | - | $111.66 M(+83.2%) |
| Dec 2012 | - | $60.95 M(+28.8%) |
| Sep 2012 | $4.85 M(+386.9%) | $47.31 M(-6.8%) |
| Jun 2012 | - | $50.78 M(+102.3%) |
| Sep 2011 | $997.00 K | $25.10 M |
FAQ
- What is Enanta Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual current assets year-on-year change?
- What is Enanta Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly current assets year-on-year change?
What is Enanta Pharmaceuticals annual total current assets?
The current annual current assets of ENTA is $299.85 M
What is the all time high annual current assets for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual total current assets is $436.84 M
What is Enanta Pharmaceuticals annual current assets year-on-year change?
Over the past year, ENTA annual total current assets has changed by -$122.94 M (-29.08%)
What is Enanta Pharmaceuticals quarterly total current assets?
The current quarterly current assets of ENTA is $299.85 M
What is the all time high quarterly current assets for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly total current assets is $451.26 M
What is Enanta Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, ENTA quarterly total current assets has changed by -$122.94 M (-29.08%)